Clinical trial
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Arm, Multicenter Study Evaluating the Efficacy and Safety of Pridopidine in Patients With Early Stage of Huntington Disease
NCT04556656 is registered in ClinicalTrials.gov with Prilenia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Arm, Multicenter Study Evaluating the Efficacy and Safety of Pridopidine in Patients With Early Stage of Huntington Disease
- Lead sponsor
- Prilenia
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 16, 2020
- Completion date
- March 21, 2024
- Enrollment
- 499 (actual)
- Sites
- 58
Conditions
As the registry lists them; a condition with its own page is linked.